Longevity & Aging · Metabolic & Cardiometabolic
hyperinsulinemia causes insulin resistance
In plain terms: Does high insulin itself cause the body to become insulin resistant rather than the other way around?
Part of: • Insulin & Metabolic Aging
On balance contradicted: controlled human studies and mechanistic work show chronic HYPERglycemia (glucotoxicity), not high insulin itself, drives insulin resistance, and insulin resistance generally precedes and causes the compensatory hyperinsulinemia — the reverse of Fung's primary-cause framing. Animal genetics show insulin CAN contribute, so a minor role isn't excluded, but insulin-as-the-cause is not supported.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Population patterns (Observational)
How the studies fall
The evidence (14)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Tripathy 2019 · J Clin Endocrinol Metab | mechanism | contradicts | moderate | Sustained physiologic hyperglycemia induced hepatic insulin resistance in healthy adults, supporting glucose- rather than insulin-driven causation. |
| Gastaldelli 2017 · Clin Sci (Lond) | observational | contradicts | moderate | Review argues insulin resistance precedes and causes metabolic (NAFLD-linked) hyperinsulinemia, the conventional direction opposite to the claim. |
| Mehran 2012 · Cell Metabolism | animal | supports | high | Genetically lowering Ins1 dosage to prevent chronic hyperinsulinemia protected mice from diet-induced obesity, adipose inflammation and hepatic steatosis, giving causal genetic evidence that hyperinsulinemia drives the downstream metabolic phenotype rather than merely compensating. |
| Wang 2016 · Int J Obesity | observational | contradicts | moderate | Mendelian randomization found genetically-instrumented obesity causally worsened insulin sensitivity and secretion, supporting an adiposity-first pathway to insulin resistance/hyperinsulinemia rather than hyperinsulinemia as the root cause. |
| Gusev E 2026 · Int J Mol Sci | observational | contradicts | low | States IR 'emerges from chronic, metabolically induced inflammation (meta-inflammation) and convergent cellular stress programs' under nutrient excess; frames IR as arising from inflammatory/stress pathways rather than from hyperi |
| Shannon 2018 · Diabetes | mechanism | mixed | moderate | Human study found chronic hyperglycemia (not hyperinsulinemia) induced insulin resistance, pointing to glucotoxicity rather than insulin itself as causal. |
| Satoh 2004 · Diabetes | animal | mixed | moderate | Chronic supraphysiological elevation of a secreted factor (resistin) induced whole-body insulin resistance with secondary hyperinsulinemia in rats, illustrating that hyperinsulinemia is often the downstream consequence of an upstream resistance-inducing signal rather than the initiating cause. |
| Li L 2025 · Front Endocrinol (Lausanne) | observational | tested-null | low | States 'dysregulated autophagy contributes to beta-cell failure and insulin resistance' in diabetes pathogenesis, framing IR as arising from autophagy dysfunction rather than from hyperinsulinemia. |
| DeFronzo 2009 · Diabetes Care | observational | mixed | moderate | Landmark clamp-based synthesis argues skeletal-muscle insulin resistance is the primary, earliest defect in type 2 diabetes with hyperinsulinemia arising as a compensatory beta-cell response, the reverse of Fung's proposed causal direction. |
| Ahmed I 2024 · J Diabetes Metab Disord | mechanism | contradicts | low | Review states oxidative stress induces aberrant DNA methylation in beta cells, perpetuating 'beta cell dysfunction' central to T2DM; frames insulin secretion/action impairment as arising from oxidative-epigenetic mechanisms, not f |
| Sundell 2003 · Diabetes | mechanism | mixed | moderate | Supraphysiological hyperinsulinemic-euglycemic clamps produced tissue-selective vascular insulin resistance in humans, demonstrating that acutely raising insulin can itself blunt insulin responsiveness in a target tissue, a mechanistic proof-of-principle for insulin-induced resistance. |
| da Silva 2020 · Can J Cardiol | mechanism | contradicts | moderate | Review concludes chronic insulin infusion does not sustainably raise blood pressure or cleanly cause insulin resistance across species, questioning hyperinsulinemia as the primary driver. |
| Ye 2025 · Nat Commun | observational | tested-null | low | Large multivariate GWAS/MR of insulin resistance identified druggable loci and treated adiposity- and tissue-level resistance as upstream drivers, with fasting insulin modeled as a correlated readout rather than the primary causal origin of insulin resistance. |
| Tarantino G 2026 · Int J Mol Sci | mechanism | contradicts | low | States IR is a 'convergent driver' with smoking/obesity/diet 'driving IR due to chronic hyperinsulinemia,' then describes hyperinsulinemia as a downstream consequence acting as a growth factor promoting bladder cancer via IGF sign |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.